Cargando…
Small-molecule inhibitor of Bcl-2 (TW-37) suppresses growth and enhances cisplatin-induced apoptosis in ovarian cancer cells
BACKGROUND: Bcl-2 plays a major role in the pathobiology and drug resistance of ovarian cancer, and inhibition of bcl-2 was useful for OC therapy. It has previously reported that TW-37, a small-molecule inhibitor of Bcl-2 family proteins, inhibited cell growth and induced apoptosis in many cancer ce...
Autores principales: | Wang, Haixia, Zhang, Zhifeng, Wei, Xiuping, Dai, Ruizhen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351907/ https://www.ncbi.nlm.nih.gov/pubmed/25823945 http://dx.doi.org/10.1186/s13048-015-0130-x |
Ejemplares similares
-
The small molecule Bcl-2/Mcl-1 inhibitor TW-37 shows single-agent cytotoxicity in neuroblastoma cell lines
por: Klenke, Stefanie, et al.
Publicado: (2019) -
Heme Oxygenase-1 is a Key Molecule Underlying Differential Response of TW-37-Induced Apoptosis in Human Mucoepidermoid Carcinoma Cells
por: Yang, In-Hyoung, et al.
Publicado: (2019) -
SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status
por: Al-Katib, Ayad M, et al.
Publicado: (2009) -
Synergistic Effects of TW-37 and ABT-263 on Renal Cell Carcinoma Cells
por: Yu, Rui, et al.
Publicado: (2021) -
The preclinical analysis of TW-37 as a potential anti-colorectal cancer cell agent
por: Lei, Shun, et al.
Publicado: (2017)